SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-19-000210
Filing Date
2019-03-19
Accepted
2019-03-19 16:57:14
Documents
2
Group Members
ORBIMED CAPITAL GP IV LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 ss129742_sc13da.htm SC 13D/A 103814
2 JOINT FILING AGREEMENT ss129742_ex9901.htm EX-1 18445
  Complete submission text file 0000947871-19-000210.txt   123917
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Subject) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90199 | Film No.: 19692079
SIC: 2836 Biological Products, (No Diagnostic Substances)